I-BRD9 is a BRD9 specific inhibitor, identified by scientists at GlaxoSmithKline. I-BRD9 is a potent and selective binder to BRD9 with a pIC50 in a Time-Resolved FRET assay of 7.3. BRD4 was used as a representative member of the BET family for initial selectivity screening, I-BRD9 displayed a pIC50 of 5.3 against this protein. (//www.thesgc.org/chemical-probes/I-BRD9)
Physicochemical Properties
| Molecular Formula | C22H22F3N3O3S2 |
| Molecular Weight | 497.5512 |
| Exact Mass | 497.105 |
| CAS # | 1714146-59-4 |
| Related CAS # | 1714146-59-4; |
| PubChem CID | 91668541 |
| Appearance | White to off-white solid powder |
| Density | 1.5±0.1 g/cm3 |
| Boiling Point | 721.0±70.0 °C at 760 mmHg |
| Flash Point | 389.9±35.7 °C |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.655 |
| LogP | 2.18 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 33 |
| Complexity | 915 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | YQYSVMKCMIUCHY-WJOKGBTCSA-N |
| InChi Code | InChI=1S/C37H48N4O4S/c1-26-9-10-30-23-33(46-32(30)21-26)35(43)40-37(15-5-6-16-37)36(44)39-31(22-27-7-3-2-4-8-27)34(42)38-24-28-11-17-41(18-12-28)25-29-13-19-45-20-14-29/h2-4,7-10,21,23,28-29,31H,5-6,11-20,22,24-25H2,1H3,(H,38,42)(H,39,44)(H,40,43)/t31-/m1/s1 |
| Chemical Name | 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-thieno[3,2-c]pyridine-2-carboximidamide |
| Synonyms | I-BRD9 I-BRD-9 I-BRD 9 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | I-BRD9 (10 μM, 6 hours) regulates immunological pathways and cancer [1]. I-BRD9 (10 μM) exhibits exceptional wider bromodomain selectivity together with robust BRD9 affinity [1]. I-BRD9 (10 μM) exhibits affinity with pIC50 values of 7.3 μM, 5.3 μM, and 6.8 μM for BRD9 (TR-FRET), BRD4 BD1 (TR-FRET), and BRD9 NanoBRET [1]. The high water solubility (CLND) of 359 μM is exhibited by I-BRD9 (10 μM)[1]. In HUT-78 cell lysates, I-BRD9 (10 μM) exhibits >625-fold selectivity for binding to endogenous BRD9 (versus BET family member BRD3) [1]. |
| Cell Assay |
RT-PCR[1] Cell Types: Kasumi-1 Cell Tested Concentrations: 10 μM Incubation Duration: 6 hrs (hours) Experimental Results: demonstrated that 4 genes (CLEC1, 62 DUSP6, 63 FES64 and SAMSN165) were strongly down-regulated and not affected by I-BET151. |
| References |
[1]. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition. J Med Chem. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~13.89 mg/mL (~27.92 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 1.39 mg/mL (2.79 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 13.9 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.0098 mL | 10.0492 mL | 20.0985 mL | |
| 5 mM | 0.4020 mL | 2.0098 mL | 4.0197 mL | |
| 10 mM | 0.2010 mL | 1.0049 mL | 2.0098 mL |